• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移动医疗检测疫苗接种后不良反应的可接受性和有效性:一项 Stimulated Telephone Assisted Rapid Safety Surveillance(STARSS)随机对照试验。

Consumer acceptability and validity of m-Health for the detection of adverse events following immunization - The Stimulated Telephone Assisted Rapid Safety Surveillance (STARSS) randomised control trial.

机构信息

Discipline of Paediatrics, Adelaide Medical School, University of Adelaide, South Australia, Australia.

Australia and New Zealand Dialysis and Transplant Registry, South Australian Health and Medical Research Institute, Adelaide, Australia.

出版信息

Vaccine. 2021 Jan 8;39(2):237-246. doi: 10.1016/j.vaccine.2020.12.011. Epub 2020 Dec 10.

DOI:10.1016/j.vaccine.2020.12.011
PMID:33309486
Abstract

INTRODUCTION

Monitoring for adverse events following immunisation (AEFI) is critical for vaccine pharmacovigilance. Given the global and expanding availability of mobile phones their utility for consumer-based vaccine safety surveillance is of interest but little is known about consumer acceptability. This study nested within the Stimulated Telephone Assisted Rapid Safety Surveillance (STARSS) randomised control trial sought to evaluate the acceptability of SMS for AEFI surveillance.

METHODS

The primary STARSS study was a multi-centre RCT evaluating the efficacy of repeated SMS prompts for AEFI surveillance with participants being adult vaccinees or parents of children receiving any vaccine. This nested study enrolled primary RCT participants who completed a detailed computer assisted telephone interview to determine their attitudes towards SMS-based surveillance and ascertain their knowledge and attitudes toward vaccine safety, efficacy, data privacy and use of electronic health records. Attitudes to surveillance and related behaviour were used as measures of acceptability.

RESULTS

20% (1200/6555) of the participants were enrolled and 1139 completed the full-length questionnaire. 96% indicated that SMS-based surveillance after immunisation to check the safety of the vaccine "should be done" but 62% of all respondents said it should be done but consent should be sought first. Neither vaccine safety attitudes nor attitudes toward privacy were associated with opposition to SMS-based surveillance. In terms of SMS related behaviour demographic rather than attitudinal factors were associated with non-compliance.

CONCLUSION

Overall, the attitude towards SMS-based surveillance was very favourable. Experiencing the SMS surveillance has the effect of reducing opposition to an SMS surveillance system, and at the same time increasing the likelihood of a preference for prior consent. Detection of a vaccine safety signal could be impeded in particular demographic groups who are non-compliant and we should undertake further research to understand why these groups are non-compliant and how this can be improved.

摘要

简介

疫苗不良事件监测(AEFI)对于疫苗药物警戒至关重要。鉴于全球和不断扩大的移动电话的可用性,它们在基于消费者的疫苗安全监测方面的实用性引起了人们的兴趣,但对于消费者的可接受性却知之甚少。这项研究嵌套在刺激电话辅助快速安全监测(STARSS)随机对照试验中,旨在评估短信用于 AEFI 监测的可接受性。

方法

主要的 STARSS 研究是一项多中心 RCT,评估了重复短信提示对 AEFI 监测的效果,参与者为接受任何疫苗的成年疫苗接种者或儿童的父母。这项嵌套研究招募了主要 RCT 参与者,他们完成了详细的计算机辅助电话访谈,以确定他们对基于短信的监测的态度,并了解他们对疫苗安全性、疗效、数据隐私和电子健康记录使用的态度。监测和相关行为的态度被用作可接受性的衡量标准。

结果

20%(1200/6555)的参与者被纳入研究,1139 人完成了完整的问卷。96%的人表示,接种疫苗后进行基于短信的监测以检查疫苗的安全性“应该进行”,但 62%的受访者表示应该进行,但首先应该征得同意。疫苗安全性态度和对隐私的态度都与反对基于短信的监测无关。就短信相关行为而言,与不遵守规定相关的是人口统计学因素,而不是态度因素。

结论

总体而言,对基于短信的监测的态度非常有利。体验短信监测会降低对短信监测系统的反对,同时增加对事先同意的偏好。在某些不遵守规定的特定人群中,可能会阻碍对疫苗安全信号的检测,我们应该进一步研究,以了解为什么这些人群不遵守规定,以及如何改进这一点。

相似文献

1
Consumer acceptability and validity of m-Health for the detection of adverse events following immunization - The Stimulated Telephone Assisted Rapid Safety Surveillance (STARSS) randomised control trial.移动医疗检测疫苗接种后不良反应的可接受性和有效性:一项 Stimulated Telephone Assisted Rapid Safety Surveillance(STARSS)随机对照试验。
Vaccine. 2021 Jan 8;39(2):237-246. doi: 10.1016/j.vaccine.2020.12.011. Epub 2020 Dec 10.
2
Efficacy of m-Health for the detection of adverse events following immunization - The stimulated telephone assisted rapid safety surveillance (STARSS) randomised control trial.移动医疗在免疫后不良事件检测中的效果 - 刺激电话辅助快速安全监测(STARSS)随机对照试验。
Vaccine. 2021 Jan 8;39(2):332-342. doi: 10.1016/j.vaccine.2020.11.056. Epub 2020 Dec 2.
3
Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial.短信移动医疗(SMS m-Health)在资源有限环境下用于免疫接种后不良反应(AEFIs)检测的效果和可行性:津巴布韦刺激电话辅助快速安全监测(Zm-STARSS)随机对照试验。
Vaccine. 2023 Oct 26;41(45):6700-6709. doi: 10.1016/j.vaccine.2023.09.037. Epub 2023 Oct 5.
4
Continuous active surveillance of adverse events following immunisation using SMS technology.使用短信技术对免疫接种后不良事件进行持续主动监测。
Vaccine. 2016 Jun 17;34(29):3350-5. doi: 10.1016/j.vaccine.2016.05.015. Epub 2016 May 17.
5
Comparison of text-messaging to voice telephone interviews for active surveillance of adverse events following immunisation.短信与语音电话访谈用于免疫接种后不良事件主动监测的比较。
Vaccine. 2015 Jul 17;33(31):3689-94. doi: 10.1016/j.vaccine.2015.06.022. Epub 2015 Jun 12.
6
Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.对“SAEFVIC”的评估,这是澳大利亚维多利亚州一项针对免疫接种后不良事件自发报告的药物警戒监测计划。
Drug Saf. 2017 Jun;40(6):483-495. doi: 10.1007/s40264-017-0520-7.
7
Active SMS-based influenza vaccine safety surveillance in Australian children.基于主动短信的澳大利亚儿童流感疫苗安全性监测。
Vaccine. 2017 Dec 18;35(51):7101-7106. doi: 10.1016/j.vaccine.2017.10.091. Epub 2017 Nov 8.
8
Using automated text messages to monitor adverse events following immunisation in general practice.利用自动化短信监测全科医疗中的疫苗接种后不良反应。
Med J Aust. 2014 Apr 21;200(7):416-8. doi: 10.5694/mja13.11166.
9
Consumer reporting of adverse events following immunization (AEFI): identifying predictors of reporting an AEFI.免疫接种后不良事件(AEFI)的消费者报告:确定报告AEFI的预测因素。
Hum Vaccin Immunother. 2014;10(3):747-54. doi: 10.4161/hv.27459. Epub 2014 Jan 9.
10
Vaccines safety; effect of supervision or SMS on reporting rates of adverse events following immunization (AEFI) with meningitis vaccine (MenAfriVac™): a randomized controlled trial.疫苗安全性;监督或短信对脑膜炎疫苗(MenAfriVac™)接种后不良事件(AEFI)报告率的影响:一项随机对照试验。
Vaccine. 2014 Sep 29;32(43):5662-8. doi: 10.1016/j.vaccine.2014.08.012. Epub 2014 Aug 23.

引用本文的文献

1
SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study.基于短信的儿童免疫接种后不良事件主动监测:VigiVax研究
Vaccines (Basel). 2024 Sep 20;12(9):1076. doi: 10.3390/vaccines12091076.
2
Active surveillance of immunization adverse effects: a multicentre, open-label, three-arm randomized uncontrolled trial in Ethiopia.免疫接种不良反应的主动监测:埃塞俄比亚的一项多中心、开放标签、三臂随机非对照试验。
Int Health. 2025 Mar 4;17(2):195-204. doi: 10.1093/inthealth/ihae040.